Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy

Annals of Surgical Oncology

Volumn 18, Issue 13, 2011, Pages 3624-3631

  Ueno, Masaki ^a   Uchiyama, Kazuhisa ^a   Ozawa, Satoru ^a   Hayami, Shinya ^a   Shigekawa, Yoshinobu ^a   Tani, Masaji ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAHEPATIC METASTASIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTRIC CARCINOGENESIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; EPIRUBICIN; ETHIODIZED OIL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 82955233510     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1800-6     Document Type: Article

References (32)

1. H Imamura Y Matsuyama E Tanaka, et al. 2003 Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol. 38 200 207 12547409 10.1016/S0168-8278(02)00360-4 (Pubitemid 36169630)
2. JM Llovet J Fuster J Bruix 1999 Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology. 30 1434 1440 10573522 10.1002/hep.510300629 1:STN:280: DC%2BD3c%2Fkt1eiug%3D%3D
3. RT Poon ST Fan IO Ng CM Lo CL Liu J Wong 2000 Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer. 89 500 507 10931448 10.1002/1097-0142(20000801) 89:3<500::AID-CNCR4>3.0.CO;2-O 1:STN:280:DC%2BD3cvgt1aktg%3D%3D (Pubitemid 30640096)
4. K Takenaka E Adachi T Nishizaki, et al. 1994 Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study Hepatology. 19 889 894 8138262 10.1002/hep.1840190414 1:STN:280:DyaK2c7os1WltQ%3D%3D (Pubitemid 24109350)
5. PJ Chen DS Chen MY Lai, et al. 1989 Clonal origin of recurrent hepatocellular carcinomas Gastroenterology. 96 527 529 2535996 1:STN:280:DyaL1M%2FptF2nuw%3D%3D
6. N Portolani A Coniglio S Ghidoni, et al. 2006 Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications Ann Surg. 243 229 235 16432356 10.1097/01.sla.0000197706.21803.a1 (Pubitemid 43185442)
7. M Sakon K Umeshita H Nagano, et al. 2000 Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves Arch Surg. 135 1456 1459 11115352 10.1001/archsurg.135.12.1456 1:STN:280:DC%2BD3M7htVemsw%3D%3D
8. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28:751-5.
9. R Tateishi H Yoshida S Shiina, et al. 2005 Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut. 54 419 425 15710994 10.1136/gut.2003.035055 1:STN:280:DC%2BD2M%2FotFKjtg%3D%3D (Pubitemid 40299102)
10. J Yamamoto T Kosuge T Takayama, et al. 1994 Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy Surgery. 115 303 309 8128355 1:STN:280:DyaK2c7nsVCiug%3D%3D (Pubitemid 24098321)
11. S Eguchi T Kanematsu S Arii, et al. 2008 Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a japanese nationwide survey Surgery. 143 469 475 18374043 10.1016/j.surg.2007.12.003 (Pubitemid 351406380)
12. SC Katz J Shia KH Liau, et al. 2009 Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma Ann Surg. 249 617 623 19300227 10.1097/SLA.0b013e31819ed22f
13. M Yamamoto S Arii K Sugahara T Tobe 1996 Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma Br J Surg. 83 336 340 8665186 10.1002/bjs.1800830313 1:STN:280:DyaK283ks1amtw%3D%3D (Pubitemid 26083165)
14. WY Lau TW Leung SK Ho, et al. 1999 Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial Lancet. 353 797 801 10459961 10.1016/S0140-6736(98) 06475-7 1:CAS:528:DyaK1MXhvFemsbc%3D (Pubitemid 29110405)
15. R Izumi K Shimizu T Iyobe, et al. 1994 Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma Hepatology. 20 295 301 8045490 10.1002/hep.1840200205 1:STN:280:DyaK2czitVyltw%3D%3D (Pubitemid 24233352)
16. K Takenaka K Yoshida T Nishizaki, et al. 1995 Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma Am J Surg. 169 400 404 7694977 10.1016/S0002-9610(99)80184-6 1:STN:280:DyaK2M3gvV2qtg%3D%3D
17. JQ Li YQ Zhang WZ Zhang YF Yuan GH Li 1995 Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy J Cancer Res Clin Oncol. 121 364 366 7541051 10.1007/BF01225689 1:STN:280:DyaK2MzhvVWqtw%3D%3D
18. T Takayama T Sekine M Makuuchi, et al. 2000 Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet. 356 802 807 11022927 10.1016/S0140-6736(00)02654-4 1:STN:280:DC%2BD3cvmvVSltg%3D%3D
19. P Mathurin B Raynard S Dharancy, et al. 2003 Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma Aliment Pharmacol Ther. 17 1247 1261 12755838 10.1046/j.1365-2036.2003.01580.x 1:CAS:528:DC%2BD3sXltleis7s%3D (Pubitemid 36693726)
20. Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev. 2009;1:CD001199.
21. E Boucher S Corbinais Y Rolland, et al. 2003 Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma Hepatology. 38 1237 1241 14578862 10.1053/jhep.2003.50473 1:CAS:528:DC%2BD3sXpsVOntrY%3D (Pubitemid 37314832)
22. M Tabone L Vigano A Ferrero R Pellerito P Carbonatto L Capussotti 2007 Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis Eur J Surg Oncol. 33 61 66 17175128 10.1016/j.ejso.2006.10.039 1:STN:280: DC%2BD2s%2Flt12msQ%3D%3D (Pubitemid 46131882)
23. M Shimoda T Bando T Nagata I Shirosaki T Sakamoto K Tsukada 2001 Prophylactic chemolipiodolization for postoperative hepatoma patients Hepatogastroenterology. 48 493 497 11379340 1:STN:280:DC%2BD3M3psVWisw%3D%3D (Pubitemid 32391598)
24. K Tanaka H Shimada S Togo, et al. 1999 Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection Hepatogastroenterology. 46 1083 1088 10370671 1:CAS:528:DyaK1MXjs1aksLw%3D (Pubitemid 29224797)
25. M Shimada K Takenaka T Gion, et al. 1996 Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan Gastroenterology. 111 720 726 8780578 10.1053/gast.1996.v111.pm8780578 1:STN:280:DyaK28znsVartQ%3D%3D (Pubitemid 26293238)
26. WY Lau EC Lai TW Leung SC Yu 2008 Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival Ann Surg. 247 43 48 18156922 10.1097/SLA.0b013e3181571047
27. E Boucher G Bouguen E Garin A Guillygomarch K Boudjema JL Raoul 2008 Adjuvant intraarterial injection of 131i-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up J Nucl Med. 49 362 366 18287267 10.2967/jnumed.107.044750 (Pubitemid 351355200)
28. S Chevret JC Trinchet D Mathieu AA Rached M Beaugrand C Chastang 1999 A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'etude et de traitement du carcinome hepatocellulaire J Hepatol. 31 133 141 10424293 10.1016/S0168-8278(99)80173-1 1:STN:280:DyaK1MzltFGkuw%3D%3D (Pubitemid 29287619)
29. B Damdinsuren H Nagano M Sakon, et al. 2003 Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs Ann Surg Oncol. 10 1184 1190 14654475 10.1245/ASO.2003.03.010 (Pubitemid 40486814)
30. K Ikeda Y Arase S Saitoh, et al. 2000 Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-a prospective randomized study of hepatitis C virus-related liver cancer Hepatology. 32 228 232 10915728 10.1053/jhep.2000.9409 1:CAS:528: DC%2BD3cXlvVyjtrk%3D (Pubitemid 30614654)
31. S Kubo S Nishiguchi K Hirohashi, et al. 2001 Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial Ann Intern Med. 134 963 967 11352697 1:CAS:528: DC%2BD3MXktF2gs70%3D (Pubitemid 32466235)
32. V Mazzaferro R Romito M Schiavo, et al. 2006 Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis Hepatology. 44 1543 1554 17133492 10.1002/hep.21415 1:CAS:528:DC%2BD2sXislKktQ%3D%3D (Pubitemid 44970357)